Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease

dc.contributor.author
Sánchez Danés, Adriana
dc.contributor.author
Richaud-Patin, Yvonne
dc.contributor.author
Carballo Carbajal, Iria
dc.contributor.author
Jiménez Delgado, Senda
dc.contributor.author
Caig, Carles
dc.contributor.author
Mora, Sergio
dc.contributor.author
Di Guglielmo, Claudia
dc.contributor.author
Ezquerra Trabalón, Mario
dc.contributor.author
Patel, Bindiben
dc.contributor.author
Giralt Torroella, Albert
dc.contributor.author
Canals i Coll, Josep M.
dc.contributor.author
Memo, Maurizio
dc.contributor.author
Alberch i Vié, Jordi, 1959-
dc.contributor.author
López Barneo, José
dc.contributor.author
Vila Farré, Miquel
dc.contributor.author
Cuervo, Ana Maria
dc.contributor.author
Tolosa, Eduardo
dc.contributor.author
Consiglio, Antonella
dc.contributor.author
Raya Chamorro, Ángel
dc.date.issued
2019-05-24T16:19:00Z
dc.date.issued
2019-05-24T16:19:00Z
dc.date.issued
2012-05
dc.date.issued
2019-05-24T16:19:00Z
dc.identifier
1757-4676
dc.identifier
https://hdl.handle.net/2445/133843
dc.identifier
615356
dc.identifier
22407749
dc.description.abstract
Induced pluripotent stem cells (iPSC) offer an unprecedented opportunity to model human disease in relevant cell types, but it is unclear whether they could successfully model age-related diseases such as Parkinson's disease (PD). Here, we generated iPSC lines from seven patients with idiopathic PD (ID-PD), four patients with familial PD associated to the G2019S mutation in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene (LRRK2-PD) and four age- and sex-matched healthy individuals (Ctrl). Over long-time culture, dopaminergic neurons (DAn) differentiated from either ID-PD- or LRRK2-PD-iPSC showed morphological alterations, including reduced numbers of neurites and neurite arborization, as well as accumulation of autophagic vacuoles, which were not evident in DAn differentiated from Ctrl-iPSC. Further induction of autophagy and/or inhibition of lysosomal proteolysis greatly exacerbated the DAn morphological alterations, indicating autophagic compromise in DAn from ID-PD- and LRRK2-PD-iPSC, which we demonstrate occurs at the level of autophagosome clearance. Our study provides an iPSC-based in vitro model that captures the patients' genetic complexity and allows investigation of the pathogenesis of both sporadic and familial PD cases in a disease-relevant cell type.
dc.format
16 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
EMBO Press
dc.relation
Reproducció del document publicat a: https://doi.org/10.1002/emmm.201200215
dc.relation
EMBO Molecular Medicine, 2012, vol. 4, num. 5, p. 380-395
dc.relation
https://doi.org/10.1002/emmm.201200215
dc.rights
(c) EMBO, 2012
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biomedicina)
dc.subject
Dopamina
dc.subject
Metabolisme
dc.subject
Fenotip
dc.subject
Genètica
dc.subject
Neurones
dc.subject
Malaltia de Parkinson
dc.subject
Patologia
dc.subject
Cèl·lules mare
dc.subject
Dopamine
dc.subject
Metabolism
dc.subject
Phenotype
dc.subject
Genetics
dc.subject
Neurons
dc.subject
Parkinson's disease
dc.subject
Pathology
dc.subject
Stem cells
dc.title
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.